You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrase strand transfer inhibitor

Showing 1 - 25 of 9,700
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

Recruiting
  • HIV Infections
  • Doravirine 100 Mg
  • +5 more
  • Birmingham, Alabama
  • +22 more
Feb 22, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV-1 Infection Trial in France (Samplings)

Recruiting
  • HIV-1 Infection
  • Samplings
  • Clamart, France
  • +6 more
Jan 4, 2022

Pre-Exposure Prophylaxis (PrEP), Breast Feeding Trial in Boston, Gaborone (Cabotegravir Injection [Apretude])

Not yet recruiting
  • Pre-Exposure Prophylaxis (PrEP)
  • Breast Feeding
  • Cabotegravir Injection [Apretude]
  • Boston, Massachusetts
  • +1 more
Aug 3, 2023

HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

Recruiting
  • HIV-1-infection
  • Kisumu, Kenya
  • +6 more
Feb 1, 2023

Virologic Failure and Drug Resistance at and After Switching to

Active, not recruiting
  • Hiv
  • +2 more
    • Lilongwe, Malawi
    • +1 more
    Feb 14, 2022

    HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

    Active, not recruiting
    • HIV-1-infection
    • Butha-Buthe, Lesotho
    • +1 more
    Oct 23, 2022

    Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

    Enrolling by invitation
    • Hiv
    • Weight Gain
    • Toronto, Ontario, Canada
      University Health Network
    May 17, 2022

    HIV Trial in Rio De Janeiro (Cabotegravir Injection)

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection
    • Rio De Janeiro, Brazil
      Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
    Aug 23, 2022

    HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

    Not yet recruiting
    • HIV Infections
    • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
    • Paris, Ile De France, France
      Christine Katlama
    Jul 26, 2022

    Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

    Not yet recruiting
    • Multi Drug Resistant Tuberculosis
    • HIV Infections
    • Adherence support intevention
    • Durban, KwaZulu-Natal, South Africa
      King DinuZulu Hospital
    Nov 21, 2022

    HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

    Recruiting
    • HIV/AIDS
    • Tuberculosis, Pulmonary
    • Biktarvy®
    • TLD- fixed-drug combination single tablet
    • Durban, KwaZulu-Natal, South Africa
      CAPRISA Springfield Clinical Research Site
    Mar 14, 2022

    HIV, Clinical Outcomes, Adverse Drug Event Trial in Salvador, São Paulo (No intervention)

    Recruiting
    • HIV Infections
    • +3 more
    • No intervention
    • Salvador, Bahia, Brazil
    • +2 more
    Mar 15, 2022

    Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

    Completed
    • Medication Adherence
    • HIV
    • dolutegravir oral tablet 50mg
    • +3 more
    • Pittsburgh, Pennsylvania
      HIV/AIDS Clinical Research Unit / University of Pittsburgh
    Mar 2, 2022

    Assess the ART Impact on the Brain Outcomes. The ARBRE Study

    Completed
    Has Results
    • HIV-1 Infection
    • Cognitive Impairment
      • (no location specified)
      May 15, 2020

      HIV-1-infection Trial in Kampala, Harare (GS-9131, BIC, TAF)

      Terminated
      Has Results
      • HIV-1-infection
      • Kampala, Uganda
      • +1 more
      Dec 7, 2020

      NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

      Not yet recruiting
      • Nonalcoholic Fatty Liver Disease
      • +3 more
        • (no location specified)
        Apr 18, 2022

        HIV-1-infection, Antiretroviral Therapy Trial in Port-au-Prince (Continuation of boosted PI, B/F/TAF)

        Not yet recruiting
        • HIV-1-infection
        • Antiretroviral Therapy
        • Port-au-Prince, Haiti
          GHESKIO
        Jul 30, 2020

        HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

        Recruiting
        • HIV Infections
        • Standard of Care (SOC) Oral ART
        • +6 more
        • Birmingham, Alabama
        • +34 more
        Dec 1, 2021

        HIV-1 Infection Trial in United States (Bictegravir, Placebo)

        Completed
        Has Results
        • HIV-1 Infection
        • Berkeley, California
        • +15 more
        Oct 16, 2020